Tarsus Pharmaceuticals (TARS) Share-based Compensation (QoQ) (2020 - 2025)
Tarsus Pharmaceuticals (TARS) Share-based Compensation (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tarsus Pharmaceuticals | 2.52 Bn | 2.41 Bn | 152.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -160.17% |
| Jun 30, 2025 | 18.80% |
| Mar 31, 2025 | -6.39% |
| Dec 31, 2024 | -63.04% |
| Mar 31, 2024 | 103.20% |
| Dec 31, 2023 | -200.00% |
| Sep 30, 2023 | 706.89% |
| Jun 30, 2023 | -152.74% |
| Mar 31, 2023 | 6.40% |
| Dec 31, 2022 | 2.46% |
| Sep 30, 2022 | 1.44% |
| Jun 30, 2022 | 32.09% |
| Mar 31, 2022 | -9.69% |
| Dec 31, 2021 | 3,848.00% |
| Sep 30, 2021 | 105.61% |
| Jun 30, 2021 | -124.34% |
| Mar 31, 2021 | 4,761.95% |
| Dec 31, 2020 | -96.35% |
| Sep 30, 2020 | 304.17% |